Explore
Trendline
Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Drive R Innovation
Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Drive R Innovation
Read More
Trendline
TRIANA Biomedicines Appoints Mohan Bala as COO, Expands Scientific Advisory Board
TRIANA Biomedicines Appoints Mohan Bala as COO, Expands Scientific Advisory Board
Read More
Trendline
Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform
Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform
Read More
Trendline
Parabilis Medicines and Regeneron Pharmaceuticals Collaborate on Novel Therapeutics
Parabilis Medicines and Regeneron Pharmaceuticals Collaborate on Novel Therapeutics
Read More
Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth
Read More
Trendline
Halia Therapeutics Expands Leadership as It Advances Inflammation Therapies
Halia Therapeutics Expands Leadership as It Advances Inflammation Therapies
Read More
Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Drive Growth
ATB Therapeutics Appoints Mark Throsby as CEO to Drive Growth
Read More
Trendline
OpenBind Launches AI Model to Revolutionize Drug Discovery with Large-Scale Data
OpenBind Launches AI Model to Revolutionize Drug Discovery with Large-Scale Data
Read More
Trendline
TRIANA Biomedicines Appoints Mohan Bala as COO to Strengthen Leadership Amid Growth
TRIANA Biomedicines Appoints Mohan Bala as COO to Strengthen Leadership Amid Growth
Read More
Trendline
Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth
Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth
Read More
Trendline
Halia Therapeutics Expands Board with New Executive Chairman and Directors Amid Strategic Growth
Halia Therapeutics Expands Board with New Executive Chairman and Directors Amid Strategic Growth
Read More
Trendline
Citius Oncology Reports Q2 2026 Financial Results Highlighting LYMPHIR Launch Success
Citius Oncology Reports Q2 2026 Financial Results Highlighting LYMPHIR Launch Success
Read More
